EMA accepts regulatory submission for avalglucosidase alfa, a potentially new standard of care enzyme replacement therapy for Pompe disease

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling